SCHEMBL6432473

SCHEMBL6432473

CC1C2=CC(=O)CCN2C2CCCCC2C1C

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 5/20 0.39
SRD5A2 P31213 3/20 0.39
GAA P10253 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6431998 0.84 SRD5A1 (0.40) SRD5A1SRD5A2
SCHEMBL6431429 0.82 SRD5A1 (0.38) SRD5A1SRD5A2
SCHEMBL6431921 0.73 ALDH1A1 (0.37) SRD5A1SRD5A2
SCHEMBL6435095 0.73 SRD5A1 (0.48) SRD5A1SRD5A2
SCHEMBL6435530 0.73 GAA (0.30) GAAHPGD
SCHEMBL6430969 0.70 SRD5A1 (0.31) SRD5A1
SCHEMBL6434893 0.65 SRD5A1 (0.33) SRD5A1SRD5A2
SCHEMBL6430856 0.64 SRD5A1 (0.45) SRD5A1SRD5A2
SCHEMBL6435838 0.64 SRD5A1 (0.48) SRD5A1SRD5A2
SCHEMBL6432789 0.62 SRD5A1 (0.43) SRD5A1SRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1066284-B1 BENZO(C)QUINOLIZINE DERIVATIVES AND THEIR USE AS 5 ALPHA-REDUCTASES INHIBITORS APPLIED RESEARCH SYSTEMS (AN) 2005-08-31 EP claimed
EP-1066284-A1 BENZO C]QUINOLIZINE DERIVATIVES AND THEIR USE AS 5 ALPHA-REDUCTASES INHIBITORS Applied Research Systems ARS Holding N.V. (AN) 2001-01-10 EP claimed
WO-1999033828-A1 BENZO[C]QUINOLIZINE DERIVATIVES AND THEIR USE AS 5 ALPHA-REDUCTASES INHIBITORS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 1999-07-08 WO claimed
EP-0926148-A1 Benzo (C)quinolizine derivatives, their preparation and use as 5-alphareductases inhibitors APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 1999-06-30 EP claimed
US-6962925-B1 Benzo(C)quinolizine derivatives and their use as 5α-reductases inhibitors APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-11-08 US disclosed
EP-1066284-B1 BENZO(C)QUINOLIZINE DERIVATIVES AND THEIR USE AS 5 ALPHA-REDUCTASES INHIBITORS APPLIED RESEARCH SYSTEMS (AN) 2005-08-31 EP disclosed
EP-1066284-A1 BENZO C]QUINOLIZINE DERIVATIVES AND THEIR USE AS 5 ALPHA-REDUCTASES INHIBITORS Applied Research Systems ARS Holding N.V. (AN) 2001-01-10 EP disclosed
WO-1999033828-A1 BENZO[C]QUINOLIZINE DERIVATIVES AND THEIR USE AS 5 ALPHA-REDUCTASES INHIBITORS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 1999-07-08 WO disclosed
EP-0926148-A1 Benzo (C)quinolizine derivatives, their preparation and use as 5-alphareductases inhibitors APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 1999-06-30 EP disclosed